Stock ZEAL ZEALAND PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:58 2024-04-30 am EDT 		5-day change 1st Jan Change
633 DKK +2.51% Intraday chart for Zealand Pharma A/S +3.60% +69.61%
Apr. 04 U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year DJ
Mar. 20 Zealand Pharma A/S Approves Appointments to the Board CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zealand Pharma A/S Approves Appointments to the Board
CI
Zealand Pharma A/S Announces Board Changes
CI
Zealand Pharma A/S Appoints Enrique Conterno and Elaine Sullivan as Board Observers
CI
Zealand Pharma A/S Announces Committee Appointments
CI
Zealand Pharma Appoints New CFO
MT
Zealand Pharma Names Henriette Wennicke Finance Chief
MT
Zealand Pharma Names David Kendall Chief Medical Officer
MT
Zealand Pharma Announces Appoints David M. Kendall, as Chief Medical Officer
CI
Zealand Pharma Names New CEO, Cuts US Workforce by 90%; Releases Revised Guidance; Shares Rise
MT
Zealand Pharma Announces CEO Changes
CI
Zealand Pharma A/S Announces Executive Changes
CI
Gertrude Koefoed Rasmussen to Step Down from the Board of Zealand Pharma A/S, Effective as of 31 August 2021
CI
Zealand Pharma A/S Announces the Promotion of Christina Sonnenborg Bredal to Head of People & Organization
CI
Zealand Pharma A/S Establishes New Scientific Committee, Which Will Comprise of Kirsten Aarup Drejer as the Chair, Michael John Owen and Alain Munoz as Members of the Committee
CI
Zealand Pharma A/S : Nomination of proxy & postal vote form
PU
Zealand Pharma A/S Announces Management Appointments
CI
Zealand Pharma A/S Appoints Mads Kronborg as Head of Investor Relations & Communication
CI
Zealand Pharma U.S. Appoints Frank Sanders as President
CI
Zealand Pharma A/S Announces Board Changes
CI
Zealand Pharma A/S Appoints Matthew Dallas as Vice President and Chief Financial Officer, Effective October 7, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. News Zealand Pharma A/S
  5. Insiders